Abstract |
We investigated whether pulmonary function and gas exchange would improve with liquid perfluorocarbon ventilation (LV) during ECMO for severe respiratory failure. Lung injury was induced in 11 young sheep 15.1 +/- 3.7 kg in weight utilizing right atrial injection of 0.07 cc/kg oleic acid followed by saline pulmonary lavage. When (A-a)DO2 > or = 600 mmHg and PaO2 < or = 50 mmHg with FiO2 = 1.0, ECMO was instituted. Animals were then ventilated with either standard ECMO "lung rest" gas ventilator settings (ECMO, n = 5) or with " total" liquid ventilation at standard ventilator device settings (LIQ-ECMO, n = 6) utilizing perflubron (perfluooctyl bromide, Liquivent; Alliance Pharmaceutical Corp.). After 3 hours on ECMO, pulmonary physiologic shunt decreased (ECMO = 88 +/- 11% vs LIQ-ECMO = 31 +/- 1%; p < .001) and pulmonary compliance increased (ECMO = 0.50 +/- 0.06 cc/cmH2O/kg vs. LIQ-ECMO = 1.04 +/- 0.19 cc/cmH2O/kg; p < .001). The ECMO flow rate required to maintain the PaO2 in the 50-80 mmHg range was decreased significantly (ECMO = 116 +/- 14 ml/kg/min vs. LIQ-ECMO = 14 +/- 5 ml/kg/min; p < .001). In this model requiring extracorporeal support for severe respiratory failure, lung management with liquid ventilation improves pulmonary function and gas exchange.
|
Authors | R B Hirschl, A Parent, R Tooley, T Shaffer, M Wolfson, R H Bartlett |
Journal | Artificial cells, blood substitutes, and immobilization biotechnology
(Artif Cells Blood Substit Immobil Biotechnol)
Vol. 22
Issue 4
Pg. 1389-96
( 1994)
ISSN: 1073-1199 [Print] England |
PMID | 7849949
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Animals
- Extracorporeal Membrane Oxygenation
- Fluorocarbons
(therapeutic use)
- Lung
(physiopathology)
- Pulmonary Gas Exchange
(drug effects)
- Respiration, Artificial
(methods)
- Respiratory Insufficiency
(physiopathology, therapy)
- Sheep
|